E. coli as a Smart Thermo-Vector for Combating Solid Tumors: A Synergistic Heat-Induced Cancer Therapy Approach

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Therapy

Background:

• Hypoxic solid tumors pose a significant challenge for conventional cancer therapies.
• Minimally invasive heat-induced cancer therapies like magnetic hyperthermia (MHCT) and photothermal ablation (PTT) show promise.
• Limited nanoparticle penetration hinders effective treatment of deep-seated or solid tumors.

Purpose of the Study:

• To develop a novel thermo-vector system for enhanced targeting and treatment of hypoxic solid tumors.
• To integrate polydopamine-coated magnetic nanoparticles with motile anaerobic bacteria (PDBs) for self-navigation.
• To evaluate the synergistic antitumor effects of combined MHCT and PTT using the PDB thermo-vector.

Main Methods:

• Development of polydopamine-coated magnetic nanoparticles integrated with anaerobic bacteria (PDBs).
• Utilizing PDBs for self-navigation within hypoxic tumor microenvironments.
• Applying alternating magnetic fields and near-infrared laser light for dual MHCT and PTT induction.
• Assessing cellular cytotoxicity, tumor targeting efficiency, and in vivo tumor regression in a mouse model.

Main Results:

• PDBs demonstrated self-navigation capabilities, effectively targeting hypoxic tumors.
• The PDB thermo-vector system achieved synergistic antitumor effects via combined MHCT and PTT.
• Heat-induced oxidative stress and mitochondrial dysfunction resulted in 80% cellular cytotoxicity within 24 hours.
• Complete tumor regression was observed in 100% of treated C57BL/6 mice within 21 days.
• Sustained tumor-free survival for 60 days without recurrence was achieved.

Conclusions:

• The developed PDB-based thermo-vector system offers a promising strategy for overcoming nanoparticle penetration limitations in solid tumors.
• This dual-modal therapy (MHCT and PTT) effectively targets and eliminates hypoxic tumors.
• The PDB approach demonstrates significant potential for advanced, minimally invasive cancer treatment with long-term efficacy.